StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Horizon Pharma (HZNP) Falls Amid Lower Outlook from Valeant
March 15, 2016 9:51 AM
Horizon Pharma (NASDAQ: HZNP) is seeing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for RAVICTI-Related Patent App
March 16, 2016 7:05 AM
Deutsche Bank Comments on Valeant Pharma (VRX) Following Q4 Call
March 15, 2016 2:20 PM
UPDATE: Piper Jaffray Downgrades Valeant Pharmaceuticals (VRX) to Underweight
March 15, 2016 11:15 AM
Valeant Pharma (VRX) Results Suggest Disruption in the Business - Evecore ISI's Raffat
March 15, 2016 10:56 AM
Valeant Pharma (VRX) Conference Call Ends
March 15, 2016 10:13 AM
